Mad Money w/Jim Cramer 4/17/23

Mad Money w/ Jim Cramer

CNBC

News, Investing, Business

4.3 • 4K Ratings

🗓️ 17 April 2023

⏱️ 45 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

The averages rose to start the week and Jim Cramer is helping investors navigate the market's moves. First up, fresh off the announcement that Merck will buy Prometheus Biosciences for $11b, Cramer's talking to Merck CEO Rob Davis and Prometheus CEO Mark McKenna to dig deeper into what the deal will mean for investors and patients. Then, the S&P has climbed 8% this year, but is more upside ahead? Cramer's going Off The Charts to find out. Plus, Cramer's exclusive with InMode CEO Moshe Mizrahy. Mad Money Disclaimer

Transcript

Click on a timestamp to play from that location

0:00.0	My mission is simple to make you money.
0:05.0	I'm here to level the playing field for all investors.
0:08.0	There's always a more market somewhere,
0:10.0	and I promise to help you find it.
0:12.0	They have money starts now.
0:17.0	Hey, I'm Kramer. Welcome to Ma'am Money.
0:19.0	Welcome to Kramerica.
0:20.0	If you want to make friends, I'm just trying to make a little money.
0:23.0	My job, not just entertainment, but to educate and teach you.
0:26.0	So call me at 1-800-730-CMBC or tweet me at some Kramer.
0:30.0	Today, today was a classic.
0:32.0	Let me start off with the tough NASDAQ sell-off, right?
0:35.0	That's the blood over the larger average.
0:37.0	Almost instantly.
0:38.0	I'm not kidding.
0:39.0	Within 15 minutes of the opening, we heard that the bull last legs.
0:43.0	That's right.
0:44.0	And here comes the big unwind.
0:45.0	This large cap tech starts rolling over.
0:49.0	We were then told, of course, that the multi-month valley was bogus all along.
0:53.0	Just a short squeeze, because the Fed's going to crush us again.
0:57.0	The next time, it tightens.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from CNBC, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of CNBC and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.